Technical analysis of Inventiva S.A. (IVA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Inventiva S.A. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of orally administered small molecule therapeutics. The firm primarily targets serious conditions such as non-alcoholic steatohepatitis (NASH), various forms of mucopolysaccharidoses (MPS), and other significant diseases.
Price Performance
| 1 month | -18.32% |
| 3 months | +6.16% |
| Year-to-date | -18.49% |
| 1 year | -28.22% |
| 3 years | -2.07% |
| 5 years | -72.73% |
52-Week Range
| 52-week High | $7.98 |
| 52-week Low | $3.35 |
| Avg Volume (90d) | 988K |
Technical Indicators
| SMA 50 | $4.54 |
| SMA 200 | $5.07 |
| Beta | 0.95 |
| 30-day Volatility (annualised) | 39.5% |
| Price vs SMA 50 | -16.5% |
| Price vs SMA 200 | -25.2% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $4.30 | |
| 2025-11 | $4.25 | -1.2% |
| 2025-12 | $4.65 | +9.4% |
| 2026-01 | $6.16 | +32.5% |
| 2026-02 | $6.49 | +5.4% |
| 2026-03 | $5.55 | -14.5% |
| 2026-04 | $5.13 | -7.6% |
| 2026-05 | $4.93 | -3.9% |
| 2026-06 | $3.78 | -23.3% |
| 2026-07 | $4.48 | +18.5% |
| 2026-08 | $4.68 | +4.5% |
| 2026-09 | $3.79 | -19.0% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | $563M |
| 2026-09-14 | | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $0.20 | $23M |
| 2026-09-14 | | |
Price
| Price | $3.79 |
| Market Cap | $197M |
| Exchange | NASDAQ |
| Country | FR |
Valuation Ratios
| Price / Book | -71.60 |
| EV / EBITDA | -5.72 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -2.10 |
| Current Ratio | 3.16 |